Jan Braune
6PUBLICATIONS
43CO-AUTHORS
Get your video featured.
Publish with JoVEGet your video featured.
Publish with JoVE
Publications (6)
Sort by Publication Date:
|Dec 18, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg
|Nov 26, 2025
The Histone Modifier KANSL2 Is an Actionable Biomarker in Multiple Myeloma.Kaiting Jiang, Marieluise Kirchner, Frederik Herzberg
|Oct 20, 2025
Chronic inflammatory demyelinating polyneuropathy (CIDP) after cilta-cel therapy.M Korenkov, J Liebaert, S Yousefian
|Jun 28, 2024
The proteogenomic landscape of multiple myeloma reveals insights into disease biology and therapeutic opportunities.Evelyn Ramberger, Valeriia Sapozhnikova, Yuen Lam Dora Ng
|Jan 09, 2023
Relapse of <i>NPM1</i>-Mutated AML with Extramedullary Manifestation 17 Years after Allogeneic Hematopoietic Stem Cell Transplantation.Jan Braune, Kathrin Rieger, Olga Blau
|Aug 02, 2022
SUMOylation inhibition overcomes proteasome inhibitor resistance in multiple myeloma.Guus J J E Heynen, Francis Baumgartner, Michael Heider
Pageof 1
Frequent Collaborators
6 joint publications
Ulrich Keller
4 joint publications
Jan Krönke
3 joint publications
Philipp Mertins
3 joint publications
Matthias Wirth
3 joint publications
Francis Baumgartner
2 joint publications
Arunima Murgai
2 joint publications
Josefine Krüger
2 joint publications
Stefan Habringer
2 joint publications
Dominik Laue
2 joint publications
Simon Haas
